Browse by UCL people
Group by: Type | Date
Jump to: Article | Conference item
Number of items: 6.
Article
Malamatari, M;
Somavarapu, S;
Taylor, KMG;
Buckton, G;
(2016)
Solidification of nanosuspensions for the production of solid oral dosage forms and inhalable dry powders.
Expert Opinion on Drug Delivery
, 13
(3)
pp. 435-450.
10.1517/17425247.2016.1142524.
|
Merchant, Z;
Buckton, G;
Taylor, KM;
Stapleton, P;
Saleem, IY;
Gulrez Zariwala, M;
Somavarapu, S;
(2016)
A new era of pulmonary delivery of nano-antimicrobial therapeutics to treat chronic pulmonary infections.
Current Pharmaceutical Design
, 22
(17)
pp. 2577-2598.
10.2174/1381612822666160317142139.
|
Pollitt, MJ;
Buckton, G;
Piper, R;
Brocchini, S;
(2015)
Measuring antibody coatings on gold nanoparticles by optical spectroscopy.
RSC Advances
, 5
(31)
pp. 24521-24527.
10.1039/c4ra15661g.
|
Taylor, K;
Malamatari, M;
Somavarapu, S;
Kachrimanis, K;
Bloxham, M;
Buckton, G;
(2016)
Preparation of theophylline inhalable microcomposite particles by wet milling and spray drying: the influence of mannitol as a co-milling agent.
International Journal of Pharmaceutics
, 514
(1)
pp. 200-211.
10.1016/j.ijpharm.2016.06.032.
|
Taylor, K;
Malamatari, M;
Somavarapu, S;
Kachrimanis, K;
Buckton, G;
(2016)
Preparation of respirable nanoparticle agglomerates of the low melting and ductile drug ibuprofen: impact of formulation parameters.
Powder Technology
, 308
pp. 123-134.
10.1016/j.powtec.2016.12.007.
|
Conference item
Malamatari, M;
Malamataris, S;
Buckton, G;
Taylor, K;
(2017)
Microcomposite particles for drug delivery to the lungs: Can they be administered as dry powders or is blending with a carrier still needed?
Presented at: Royal Pharmaceutical Society (RPS) Winter Summit 2017, London, UK.
|